$3.29 +0.07 (2.17%)

Sensus Healthcare, Inc (SRTS)

Sensus Healthcare, Inc. (SRTS) specializes in developing and manufacturing innovative, non-invasive medical devices for the treatment of skin conditions and non-melanoma skin cancers. The company's products leverage advanced nanosecond pulsed laser and targeted microwave technology to provide safe and effective solutions for dermatological and oncological treatments.

🚫 Sensus Healthcare, Inc does not pay dividends

Company News

MAREX REMINDER: Bragar Eagel & Squire, P.C. Reminds Marex Group Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Marex Stockholders
GlobeNewswire Inc. • Bragar Eagel & Squire, P.C. • October 9, 2025

Law firm investigating potential securities law violations by Marex Group after a research report alleging accounting irregularities caused stock price decline.

Recent Price Trend in Sensus Healthcare is Your Friend, Here's Why
Benzinga • Zacks • August 30, 2024

The article discusses the recent positive price trend in Sensus Healthcare (SRTS) and why it is a good investment opportunity. The stock has seen a steady increase in price over the past 12 weeks and 4 weeks, indicating a bullish trend. Additionally, the stock is trading at a high percentage of its 52-week range and has a favorable Zacks Rank and...

Sensus Healthcare, Inc. (SRTS) Stock Sinks As Market Gains: Here's Why
Zacks Investment Research • Zacks Equity Research • June 25, 2024

In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $4.87, marking a -1.81% move from the previous day.

Sensus Healthcare, Inc. (SRTS) Moves 5.1% Higher: Will This Strength Last?
Investing.com • Zacks Investment Research • January 13, 2022